Showing 541-560 of 8668 for: Cochrane Systematic Reviews Back
- Antibiotics to prevent complications following tooth extractions
Cochrane Systematic Reviews, 24-Feb-2021
The most frequent indications for tooth extractions, generally performed by general dental practitioners, are dental caries and periodontal infections. Systemic antibiotics may be prescribed to patients undergoing extractions to prevent complications due
- Antibiotics to reduce post‐tonsillectomy morbidity
Cochrane Systematic Reviews, 12-Dec-2012
This is an update of a Cochrane Review first published in The Cochrane Library in Issue 2, 2008 and previously updated in 2010.
- Antibiotics versus no treatment for toxoplasma retinochoroiditis
Cochrane Systematic Reviews, 20-May-2016
Acute toxoplasma retinochoroiditis causes transient symptoms of ocular discomfort and may lead to permanent visual loss. Antibiotic treatment aims primarily to reduce the risk of permanent visual loss, recurrent retinochoroiditis, and the severity and dur
- Antibiotics versus placebo for acute bacterial conjunctivitis
Cochrane Systematic Reviews, 1-Aug-2012
Acute bacterial conjunctivitis is an infection of the conjunctiva. Both the palpebral and the bulbar ocular conjunctival surfaces are usually affected and typically become red and inflamed. Antibiotic therapy is widely used for the treatment of acute bact
- Antibiotics versus placebo for prevention of postoperative infection after appendicectomy.
Cochrane Systematic Reviews, 20-Jul-2005
Appendicitis is the most common cause of acute abdominal pain requiring surgical intervention. The cause of appendicitis is unclear and the mechanism of pathogenesis continues to be debated. Despite improved asepsis and surgical techniques, postoperative
- Antibiotics versus topical antiseptics for chronic suppurative otitis media
Cochrane Systematic Reviews, 5-Jan-2020
Chronic suppurative otitis media (CSOM), sometimes referred to as chronic otitis media (COM), is a chronic inflammation and infection of the middle ear and mastoid cavity, characterised by ear discharge (otorrhoea) through a perforated tympanic membrane.
- Antibody induction therapy for lung transplant recipients
Cochrane Systematic Reviews, 27-Nov-2013
Lung transplantation has become a valuable and well-accepted treatment option for most end-stage lung diseases. Lung transplant recipients are at risk of transplanted organ rejection, and life-long immunosuppression is necessary. Clear evidence is essenti
- Antibody induction versus corticosteroid induction for liver transplant recipients
Cochrane Systematic Reviews, 31-May-2014
Liver transplantation is an established treatment option for end-stage liver failure. To date, no consensus has been reached on the use of immunosuppressive T-cell specific antibody induction compared with corticosteroid induction of immunosuppression aft
- Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients
Cochrane Systematic Reviews, 9-Jul-2014
Liver transplantation is an established treatment option for end-stage liver failure. To date, no consensus has been reached on the use of immunosuppressive T-cell antibody induction for preventing rejection after liver transplantation.
- Antibody tests for identification of current and past infection with SARS‐CoV‐2
Cochrane Systematic Reviews, 25-Jun-2020
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus and resulting COVID-19 pandemic present important diagnostic challenges. Several diagnostic strategies are available to identify current infection, rule out infection, identify people
- Antibody therapies for lymphoma in children
Cochrane Systematic Reviews, 19-Jan-2016
Lymphomas are the third most common malignancy in childhood. Cure rates are high but have reached a plateau. Therefore new treatment modalities should be developed. Antibody therapy is a successful new treatment option in adult lymphoma. However, none of
- Anticholinergic agents for chronic asthma in adults
Cochrane Systematic Reviews, 19-Jul-2004
Anticholinergic agents such as ipratropium bromide are sometimes used in the treatment of chronic asthma. They effect bronchodilation and have also been used in combination with ß2 -agonists in the management of chronic asthma.
- Anticholinergic bronchodilators versus beta2‐sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 20-Jan-2003
Inhaled bronchodilators form the mainstay of treatment for acute exacerbations of COPD. Two types of agent are used routinely, either singly or in combination: anticholinergic agents and beta2-sympathomimetic agonists.
- Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome
Cochrane Systematic Reviews, 5-May-2021
Medications with anticholinergic properties are commonly prescribed to older adults. The cumulative anticholinergic effect of all the medications a person takes is referred to as the 'anticholinergic burden' because of its potential to cause adverse effec
- Anticholinergic drugs for wheeze in children under the age of two years
Cochrane Systematic Reviews, 20-Jul-2005
Wheeze in infancy and early childhood is common and appears to be increasing though the magnitude of any increase is unclear. Most wheezing episodes in infancy are precipitated by respiratory viral infections. Treatment of very young children with wheeze
- Anticholinergic drugs versus non‐drug active therapies for non‐neurogenic overactive bladder syndrome in adults
Cochrane Systematic Reviews, 12-Dec-2012
Overactive bladder syndrome is defined as urgency with or without urgency incontinence, usually with frequency and nocturia. Pharmacotherapy with anticholinergic drugs is often the first line medical therapy, either alone or as an adjunct to various non-p
- Anticholinergic drugs versus other medications for overactive bladder syndrome in adults
Cochrane Systematic Reviews, 17-Oct-2007
Overactive bladder syndrome is defined as "urgency with or without urge incontinence, usually with frequency and nocturia". It is a common condition with significant economic and quality of life implications. While the condition's pathophysiology remains
- Anticholinergic drugs versus placebo for overactive bladder syndrome in adults
Cochrane Systematic Reviews, 18-Oct-2006
Around 16% of adults have symptoms of overactive bladder (urgency with frequency and/or urge incontinence). The prevalence increases with age. Anticholinergic drugs are commonly used to treat this condition.
- Anticholinergic medication for antipsychotic‐induced tardive dyskinesia
Cochrane Systematic Reviews, 17-Jan-2018
Antipsychotic (neuroleptic) medication is used extensively to treat people with serious mental illnesses. However, it is associated with a wide range of adverse effects, including movement disorders. Because of this, many people treated with antipsychotic
- Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia
Cochrane Systematic Reviews, 10-Oct-2013
Treatment of schizophrenia depends heavily on neuroleptic drugs. Hypersalivation is a common side effect when people with schizophrenia are treated with neuroleptic drugs. Hypersalivation can be an embarrassing and stigmatising problem, can affect quality
